Importance of serum phosphate in elderly patients with diabetes mellitus

被引:7
作者
Raikou, Vaia D. [1 ]
Kyriaki, Despina [2 ]
Gavriil, Sotiris [3 ]
机构
[1] Doctors Hosp, Dept Nephrol, 26 Kefallinias, Athens 11257, Greece
[2] Gen Hosp LAIKO, Dept Nucl Med, Athens 11527, Greece
[3] Doctors Hosp, Dept Bariatr Surg, Athens 11257, Greece
关键词
Serum phosphate; Diabetes mellitus; Renal disease; Old age; Albuminuria; Vitamin D; INSULIN-SECRETION; DISEASE; HYPERTENSION; ASSOCIATION; PHOSPHORUS; MORTALITY; OUTCOMES; CALCIUM;
D O I
10.4239/wjd.v11.i10.416
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Metabolic disturbances including changes in serum calcium, magnesium or phosphate (P) influence the prevalence of type 2 diabetes mellitus (DM). We assessed the importance of serum P in elderly patients with type 2 DM vs non-diabetes mellitus (non-DM) in relation to renal function. AIM To determine the association between serum P and serum glucose or insulin resistance in diabetic and non-diabetic patients. METHODS One hundred-ten subjects with a mean age of 69.02 14.3 years were enrolled. Twenty-nine of the participants had type 2 DM (26.4%). The incidence of hypertension, smoking and receiving vitamin D (vitD) derivates were recorded. The participants were classified by both estimated glomerular filtration rate (eGFR) and albuminuria categories according to the Kidney Disease Improving Global Outcomes 2012 criteria. RESULTS We divided the patients in two groups according to the P cut-off point related to DM value. A comparison between high and low P showed that body mass index 30.2 +/- 6.3 vs 28.1 +/- 4.6 (P = 0.04), mean glucose 63.6 vs 50.2 (P = 0.03), uric acid 6.7 +/- 1.6 vs 6.09 +/- 1.7 (P = 0.05), mean intact-parathyroid hormone 68.06 vs 47.4 (P = 0.001), systolic blood pressure 147.4 +/- 16.7 vs 140.2 +/- 16.1 (P = 0.02), mean albuminuria 63.2 vs 50.6 (P = 0.04) and eGFR 45.6 +/- 22.1 vs 55.4 +/- 21.5 (P = 0.02) were significantly different. chi(2) tests showed a significant association between high P and DM, hypertension, receiving vitD, smoking and eGFR stage (chi(2) = 6.3, P = 0.01, chi(2) = 3.9, P = 0.03, chi(2) = 6.9, P = 0.009, chi(2) = 7.04, P = 0.01 and chi(2) = 7.36, P = 0.04, respectively). The adjusted model showed that older age, female gender and increased body mass index were significant predictors of type 2 DM when entering the covariates. CONCLUSION High serum P contributes to vascular and metabolic disturbances in elderly patients with type 2 DM and renal impairment.
引用
收藏
页码:416 / 424
页数:9
相关论文
共 25 条
  • [11] Prediction of all-cause mortality in a patient population with hypertension and type 2 DM by using traditional risk factors and serum-phosphate, -calcium and -magnesium
    Haglin, L.
    Toernkvist, B.
    Baeckman, L.
    [J]. ACTA DIABETOLOGICA, 2007, 44 (03) : 138 - 143
  • [12] A structural equation model for assessment of links between changes in serum triglycerides, -urate, and -glucose and changes in serum Calcium, -magnesium and -phosphate in Type 2 diabetes and non-diabetes metabolism
    Haglin, Lena
    Backman, Lennart
    Tornkvist, Birgitta
    [J]. CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [13] High serum phosphate and triglyceride levels in smoking women and men with CVD risk and type 2 diabetes
    Haglin, Lena M.
    Tornkvist, Birgitta
    Backman, Lennart O.
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [14] Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: A reliable tool for assessment of vitamin D status
    Neyestani, Tirang R.
    Gharavi, A'azam
    Kalayi, Ali
    [J]. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2007, 77 (05) : 341 - 346
  • [15] Geriatric Nephrology: Responding to a Growing Challenge
    Rosner, Mitchell
    Abdel-Rahman, Emaad
    Williams, Mark E.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (05): : 936 - 942
  • [16] Sesso Ricardo Cintra, 2017, Braz. J. Nephrol., V39, P261, DOI 10.5935/0101-2800.20170049
  • [17] Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
    Sigrist, Mhairi
    Tang, Mila
    Beaulieu, Monica
    Espino-Hernandez, Gabriella
    Er, Lee
    Djurdjev, Ognjenka
    Levin, Adeera
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) : 161 - 169
  • [18] Impact of abdominal fat and insulin resistance on arterial hypertension in non-obese women
    Silva, Eliana A.
    Flexa, Fernando
    Zanella, Maria Teresa
    [J]. ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (03) : 340 - 343
  • [19] Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
    Stevens, Paul E.
    Levin, Adeera
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 158 (11) : 825 - +
  • [20] Relation between serum phosphate level and cardiovascular event rate in people with coronary disease
    Tonelli, M
    Sacks, F
    Pfeffer, M
    Gao, ZW
    Curhan, G
    [J]. CIRCULATION, 2005, 112 (17) : 2627 - 2633